Purchase Order VA26014P2888

This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, for the supply of radiopharmaceutical products. The contract has a ceiling value of $51,390.92 and a period of performance through December 31, 2024. The award is for the provision of critical radiopharmaceuticals, such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate (NETSPOT), which are used in...

This is a $488,270.50 firm fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Southeast Apothecary Opelika, Inc., a woman-owned small disadvantaged business, for the delivery of unit dose radiopharmaceuticals to Martin Army Community Hospital at Fort Benning, Georgia. The contract has an ultimate completion date of September 30, 2025. This award was not set aside for any specific small business program. The original pre-solicitation notice, posted on October 2, 2020,...

This is a federal contract award issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals. The $108,500 firm-fixed-price delivery order is for the radiopharmaceutical drug DOTATATE, which is used in nuclear medicine procedures. The contract is not set aside and is awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle....

This contract award is for the supply of radiopharmaceuticals to the Defense Health Agency (DHA), a component of the Department of Defense (DoD). The contract was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company specializing in the distribution of pharmaceuticals and medical products. The contract has a ceiling value of $738,865.37 and is structured as a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) contract. The...

This is a federal contract awarded by the Defense Health Agency (DHA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The contract, valued at $258,331.00, is for the delivery of MERTIATIDE MAG3, COMPOUNDED R057A0 I-131 CAPSULES, a radiopharmaceutical product used for diagnostic imaging and treatment procedures. The contract is a firm-fixed-price purchase order without any set-aside designation. Jubilant Radiopharma is a for-profit, self-certified small...

The Department of Veterans Affairs (VA) Veterans Health Administration awarded a delivery order contract to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., to provide unit dose radiopharmaceuticals for nuclear medicine at the Fort Wayne, Indiana VA Medical Center. The contract, which does not have a set-aside designation, has a potential value of $495,531.20 and runs through September 30, 2022. Cardinal Health 414 provides a range of pharmaceutical products and services,...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $4,031,438 firm fixed price delivery order to Advanced Accelerator Applications USA Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is for the delivery of 20 doses of Lutetium (Lu177) DOTATATE and 100 doses of Lutetium (Lu177) PSMA, with performance through February 5, 2025. Advanced Accelerator Applications USA Inc. is a radiopharmaceutical...

This is a federal delivery order contract awarded by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer...

The Department of Veterans Affairs Veterans Health Administration awarded a delivery order to Cardinal Health 414, LLC for the supply of unit dose radiopharmaceuticals for nuclear medicine at the Fort Wayne, IN VA Medical Center. The firm fixed price contract, which does not have a set-aside designation, was exercised for option year 1 and has a potential value of $105,596.32. Cardinal Health 414, LLC is a subsidiary of the global healthcare services company Cardinal Health, Inc., which has...

This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The contract, worth up to $80,000.00, is for the delivery of various radiopharmaceuticals to military treatment facilities to support nuclear medicine diagnostic services for active duty...